These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
651 related items for PubMed ID: 14618198
1. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure. Wozakowska-Kapłon B, Opolski G. Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198 [Abstract] [Full Text] [Related]
2. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B, Opolski G. Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [Abstract] [Full Text] [Related]
3. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation. Kosior DA, Stawicki S, Wozakowska-Kapłon B, Szulc M, Opolski G, Rabczenko D. Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427 [Abstract] [Full Text] [Related]
4. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. Opolski G, Torbicki A, Kosior D, Szulc M, Zawadzka M, Pierścińska M, Kołodziej P, Stopiński M, Wozakowska-Kapłon B, Achremczyk P, Rabczenko D. Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344 [Abstract] [Full Text] [Related]
5. Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion. Kubac G, Malowany L. Can J Cardiol; 1992 Nov; 8(9):941-6. PubMed ID: 1486544 [Abstract] [Full Text] [Related]
6. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG. Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313 [Abstract] [Full Text] [Related]
7. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation. Wozakowska-Kapłon B, Opolski G, Janion M. Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556 [Abstract] [Full Text] [Related]
8. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H, Binici S, Ari S, Akkaya M, Koca V, Bozat T, Gürdoğan M. Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [Abstract] [Full Text] [Related]
9. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Goudis CA, Maliaraki NE, Saloustros IG, Milathianaki ME, Chlouverakis GI, Vardas PE. Am J Cardiol; 2010 Jan 01; 105(1):90-4. PubMed ID: 20102897 [Abstract] [Full Text] [Related]
10. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. Int J Cardiol; 2006 Apr 14; 108(3):346-53. PubMed ID: 15964643 [Abstract] [Full Text] [Related]
11. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure. Wojtkowska I, Sobkowicz B, Musiał WJ, Kozuch M. Kardiol Pol; 2006 Aug 14; 64(8):777-83; discussion 784-5. PubMed ID: 16981052 [Abstract] [Full Text] [Related]
12. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B, Opolski G. Kardiol Pol; 2009 Mar 14; 67(3):254-61. PubMed ID: 19378231 [Abstract] [Full Text] [Related]
13. Importance of heart rate during exercise for response to cardiac resynchronization therapy. Maass AH, Buck S, Nieuwland W, Brügemann J, van Veldhuisen DJ, Van Gelder IC. J Cardiovasc Electrophysiol; 2009 Jul 14; 20(7):773-80. PubMed ID: 19207785 [Abstract] [Full Text] [Related]
14. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P. Eur Heart J; 2000 Jun 14; 21(11):927-34. PubMed ID: 10806017 [Abstract] [Full Text] [Related]
15. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. Kapoor A, Kumar S, Singh RK, Pandey CM, Sinha N. J Heart Valve Dis; 2002 Nov 14; 11(6):802-9. PubMed ID: 12479281 [Abstract] [Full Text] [Related]
16. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation. Wozakowska-Kaplon B, Bartkowiak R, Janiszewska G. Pacing Clin Electrophysiol; 2010 May 14; 33(5):561-5. PubMed ID: 20059712 [Abstract] [Full Text] [Related]
17. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM. Am J Cardiol; 2007 May 01; 99(9):1252-7. PubMed ID: 17478153 [Abstract] [Full Text] [Related]
18. Biphasic transoesophageal vs. transthoracic electrical cardioversion of persistent atrial fibrillation. Mazza A, Fera MS, Pugliese M, Leggio M, Bendini MG, Poli V, Manzara C, Minardi G, Pino PG, Pompa D, Fiorella AT, De Santis F, Giovannini E. J Cardiovasc Med (Hagerstown); 2006 Aug 01; 7(8):594-600. PubMed ID: 16858238 [Abstract] [Full Text] [Related]
19. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure. Beukema WP, Sie HT, Misier AR, Delnoy PP, Wellens HJ, Elvan A. Eur J Cardiothorac Surg; 2008 Oct 01; 34(4):771-5. PubMed ID: 18768326 [Abstract] [Full Text] [Related]
20. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, Pini D, Ceriotti C, Gronda E, Klersy C, Fratini S, Klein HH. J Am Coll Cardiol; 2006 Aug 15; 48(4):734-43. PubMed ID: 16904542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]